Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancer

There is an urgent need for new treatment options in metastatic drug-resistant prostate cancer. Combining immunotherapy with other targeted therapies may be an effective strategy for advanced prostate cancer. In the present study, we sought to investigate to enhance the efficacy of anti-CTLA-4 thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Witt, Kristina, Evans-Axelsson, Susan, Lundqvist, Andreas, Johansson, Martin, Bjartell, Anders, Hellsten, Rebecka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505385/
https://www.ncbi.nlm.nih.gov/pubmed/33786638
http://dx.doi.org/10.1007/s00262-021-02915-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505385/
https://www.ncbi.nlm.nih.gov/pubmed/33786638
http://dx.doi.org/10.1007/s00262-021-02915-6

Ejemplares similares